LONDON, March 1, 2016 /PRNewswire/ -- Prevtec Microbia will present at CleanEquity Monaco 2016 on March 3rd & 4th at the Oceanographic Museum of Monaco.
Other partners and sponsors include Prince Albert II of Monaco Foundation, Covington & Burling, Cranfield University, Parkview, PR Newswire, Deloitte, INNEON, Gillamor Stephens,Enereau, the Monte-Carlo SBM, The Monaco Economic Board, International University of Monaco and the Oceanographic Museum of Monaco.
Prevtec Microbia has been identified by an expert panel as one of the world's most innovative cleantech companies and has been selected to present to senior financial and strategic cleantech investors, policy makers, legislators, end users and media.
Prevtec Microbia is a private Canadian biotechnology company developing vaccines and other technologies for the prevention of diseases in food animals. The Company's mission is to develop and market biological products as alternatives to antibiotics, to offer sustainable solutions that contribute to improving animal health, production performance and food safety.
Prevtec Microbia's first commercial product, Coliprotec®F4, a swine E. coli vaccine, has been sold across Canada since 2008. In March 2015, Prevtec Microbia was granted a market authorization for Coliprotec F4 in the European Union and the product is distributed by Elanco, the second largest animal health company in the world. Please visit us at www.prevtecmicrobia.com.
About Innovator Capital
Innovator Capital is a specialist investment bank advising emerging technology companies from around the world. Established in 2003, Innovator focuses on the provision of expert strategic and capital markets advice, transaction arranging and M&A services for private and public companies.
SOURCE Innovator Capital